Jasper Therapeutics, Inc.
JSPR
$0.46
$0.00-0.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.95% | -44.98% | -63.01% | -58.81% | -17.55% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.01% | 17.13% | 46.62% | 30.63% | 32.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 65.90% | 147.21% | 236.87% | 1,232.29% | 323.41% |
| Total Current Assets | -54.30% | -42.45% | -60.47% | -55.80% | -14.76% |
|
|
|||||
| Total Current Assets | -54.30% | -42.45% | -60.47% | -55.80% | -14.76% |
| Net Property, Plant & Equipment | -78.81% | -26.41% | -21.20% | -8.94% | -32.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -57.15% | -60.35% | -61.46% | -48.42% | -29.72% |
| Total Assets | -55.22% | -42.19% | -59.21% | -54.27% | -15.80% |
|
|
|||||
| Total Accounts Payable | 54.46% | 197.02% | 171.05% | 25.26% | -2.94% |
| Total Accrued Expenses | -42.02% | 35.42% | 85.57% | 40.55% | 39.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.41% | 60.81% | 89.89% | 83.50% | 12.04% |
| Total Finance Division Other Current Liabilities | -71.36% | -92.58% | -77.52% | -11.58% | 32.18% |
| Total Other Current Liabilities | -71.36% | -92.58% | -77.52% | -11.58% | 32.18% |
| Total Current Liabilities | -13.37% | 68.88% | 103.62% | 38.34% | 23.14% |
|
|
|||||
| Total Current Liabilities | -13.37% | 68.88% | 103.62% | 38.34% | 23.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -84.38% | -51.38% | -60.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 713.96% | 997.92% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 73.54% | 191.73% | 68.62% | 20.58% | 10.78% |
|
|
|||||
| Common Stock & APIC | 6.04% | 6.30% | 4.73% | 2.63% | 21.97% |
| Retained Earnings | -31.47% | -42.03% | -45.94% | -42.97% | -42.02% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -93.27% | -86.17% | -76.57% | -62.69% | -21.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.27% | -86.17% | -76.57% | -62.69% | -21.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -93.27% | -86.17% | -76.57% | -62.69% | -21.37% |
|
|
|||||